Trump Administration Plans 100% Tariffs on Pharmaceutical Imports 
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions 
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown 
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding? 
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman 
Luxury Car Sales in the Middle East Take a Hit Amid Iran War 
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition 
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs 
TSMC Japan's Second Fab to Produce 3nm Chips by 2028 
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO 
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO 
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure 
Apple Turns 50: From Garage Startup to AI Crossroads 
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook 
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment 
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers 
NEW YORK, Jan. 17, 2017 -- Dr. Yuri Lyubchenko of the University of Nebraska Medical Center has been selected to join the Education Board at the American Health Council. He will be sharing his knowledge and expertise on Nanomedicine, Biophysics, and Nanotechnology.
|
|||||
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/bd4362a5-3876-43b3-bca4-6302b9123537
As a professor at the University of Nebraska Medical Center since 2004, Dr. Lyubchenko utilizes his platform as an opportunity to prepare the next generation of scientists. University of Nebraska Medical Center serves as the only public academic health sciences center committed to educating the healthcare work force to discover cures and treatments to provide the best care for patients. Dr. Lyubchenko’s day-to-day responsibilities consist of teaching biophysics and biochemistry, pharmaceutical courses, guiding graduates and professionals, conducting research, writing grants, and nanoimaging.
In 1971, Dr. Lyubchenko earned his PhD in Biophysics and Nanomedicine from Moscow Institute of Physics and Technology.
Dr. Lyubchenko maintains affiliations with the following organizations: American Chemical Society, Biophysical Society, American Association for Pharmaceutical Science, and American Association of Advancement of Science. Additionally, Dr. Lyubchenko volunteers with the US Against Alzheimer.
Dr. Lyubchenko’s interest in the field of Biophysics and Nanomedicine, developed after receiving encouragement from his physics high school teacher. He attributes his success to being goal-driven and hard work.
Among his many accomplishments, he is most proud to have written more than two hundred and fifty-four peer reviewed publications.
Due to his unwavering dedication to biophysics, Dr. Lyubchenko is recognized as the 2008 Distinguished Scientist.
Looking ahead, Dr. Lyubchenko hopes for continual growth in research and his personal life.
In his free time, Dr. Lyubchenko enjoys skiing, biking, and reading. Born in Siberia, Russia, he is fluent in Russian. As a graduate student, Dr. Lyubchenko learned Japanese and still remembers how to write “Japan” with characters.
For more information, please contact: Elizabeth Moore American Health Council Hauppauge, NY United States Phone: 1-212-390-0214 Email: [email protected]
